View Clinical Trial (Medical Research Study)
A Phase I Study of Pazopanib in Adult Patients With Liver Cancer - NCT00370513-94115(Clinical Trial 148094)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
San Francisco |
|
State:
|
|
CA |
| Zip Code: |
|
94115 |
| Conditions: |
|
Liver Cancer |
| Purpose: |
|
Liver cancer is a good target for anti-angiogenic treatments such as pazopanib. The effect
of pazopanib in patients with liver cancer are unknown. This study is designed to evaluate
the safety, tolerability and best dose of pazopanib to be given to patient with liver
cancer.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion criteria:
- Diagnosis of advanced liver cancer adequate bone marrow, liver and kidney function
- Any local therapy for tumor must have been completed at least 4 weeks prior to
enrolling in study
Exclusion criteria:
- Pregnant or breastfeeding
- Any serious or unstable medical or psychiatric conditions
- History of metastases to central nervous system
- History of ulcer, inflammatory bowel disease or disease of the gut
- History of HIV, or uncontrolled infection
- Have had a cardiac condition or stoke during the past 6 months
- High blood pressure
- Have had a blood clot during the past 6 months
- History of bleeding blood vessels |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 15, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|